We are thrilled to announce that our project, ‘Identifying T cell-specific glucocorticoid receptor agonists for the treatment of rheumatoid arthritis,’ was selected to receive funding by the UAB Rheumatic Diseases Core Center. This project has been near and dear to my heart for years, although relegated to the back burner due to lack of funding – too risky, as some funding agencies described it (we’re looking at you, NIH). Thanks UAB RDCC for taking a chance on us. We won’t disappoint.